−£22k
−137%vs Feb 2024Active14632770Private limited companyThornbury
LAYANSON PHARMA LTD
D35/10001
Summary
LAYANSON PHARMA LTD is an active private limited company (company number 14632770) incorporated on 1 February 2023, registered in Thornbury. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest small accounts cover the period ending 28 February 2025, showing net assets of −£22k and cash of £90k, with 19 employees on average. Turnover was £1.27m and profit for the year −£72k. Net assets fell 137% on the prior period (£58k).
Peer position · net assets
By net assets it sits in the bottom quarter of 1,797 comparable companies in the UK (median £3,718, upper quartile £148k).
02
Key dates
- Incorporated
- 1 February 20233 yrs ago
- Next accounts due
- 28 November 2026in 37 days
- Confirmation statement due
- 15 February 2027in 116 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 47730
- Dispensing chemist in specialised stores
- SIC 86900
- Other human health activities
- Accounts type
- Total Exemption Full
- Size band
- SmallCompanies Act thresholds
04
Financials
£90k
+287%vs Feb 2024£1.27m
+85%vs Feb 202419
+90%vs Feb 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 28 February 2025 | −£22k | £90k | £197k | £310k | £1.27m | −£72k | 19 |
| 29 February 2024 | £58k | £23k | £285k | £297k | £687k | £58k | 10 |
Current ratio1.1Current assets ÷ creditors within one year
Net margin-5.6%Profit for the year ÷ turnover
Cash per employee£4,745Cash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
05
Firmoscan score
35 / 100 · grade D
| 50 | Starting scoreEvery scored company starts here |
| −15 | Negative net assetsNet assets £-21,542 at 2025-02-28 |
| −8 | Net assets falling-136.9% vs prior period |
| +4 | Cash reservesCash £90,159 |
| +4 | Past first filingsIncorporated 2023-02-01 |
| 35 | Score, grade D |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Mr Adedamola Layade
- owns 75–100% of shares
- owns 75–100% of shares
- owns 75–100% of shares
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- can appoint or remove directors
- can appoint or remove directors
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Confirmation statement duein 116 days
- Next accounts duein 37 days
- Accounts period endNet liabilities £22k · small accounts
- Accounts period endNet assets £58k · small accounts
- Incorporated
08
Similar companies in Bristol
- ZYDUS PHARMACEUTICALS UK LTDBristol · inc. Feb 2023
- CURA PHARMA SERVICES LTDWestbury · inc. Nov 2022
- ASCLEPIUS & PANACEA CONSULTANCY LIMITEDBristol · inc. Oct 2022
- EVOLUTION XET LTDBristol · inc. Oct 2023
- GREAT FRAMES LTDYeovil · inc. Oct 2023
- FRANCESCO PERRA LTDBristol · inc. Mar 2022
All companies incorporated on 1 February 2023 · in Feb 2023.
09
Reminders for LAYANSON PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.